دراسة تأثير هرمون النمو في مستويات الكرياتينين والوزن لدى الأرانب: دراسة أولية

شعيب الأحمد; خالد كريج; نوار بدور; بكر جمران; عبد الهادي دياب; محمد ملوك

doi:10.5281/zenodo.21067084

Authors

Dr. Shuaib Al-Ahmad Al Wataniya Private University
Khaled Kreij Al Wataniya Private University
Nawar Bdoor Al Wataniya Private University
Bakr Jamran Al Wataniya Private University
Abdulhadi Diab Al Wataniya Private University
Mohammed Malouk Al Wataniya Private University

DOI:

https://doi.org/10.5281/zenodo.21067084

Keywords:

Growth Hormone, GH, Creatinine, Weight, Rabbits, Kidney Function

Abstract

Given the high rates of irresponsible misuse of growth hormone (GH) in sports for muscle mass gain and performance enhancement, it is crucial to investigate its potential side effects, particularly on renal function, which may be affected by such practices. This pilot study aimed to evaluate the effect of GH administration on body weight and plasma creatinine levels in adult male rabbits. Sixteen male rabbits, 7 months old and weighing an average of 2 kg, were divided into two equal groups (n=8): an untreated control group and a treatment group injected subcutaneously with GH at a dose of 16 IU daily for 10 days. After treatment, blood samples were drawn from the heart, plasma was separated, and creatinine levels were measured. The results showed a significant increase in creatinine in the GH group compared to the control group (4.93 ± 0.27 mg/dL vs. 2.05 ± 0.17 mg/dL, p<0.05). A clear and statistically significant increase in the weights of rabbits treated after injection compared to before injection was observed: 2.7±0.35 kg versus 1.91±0.22 kg (p<0.05). This reflects the strong anabolic effect of growth hormone, especially at high doses, associated with a significant weight gain and possible renal functional changes that go beyond just an increase in muscle mass, which necessitates strict monitoring of renal indicators during its use.

Downloads

Download data is not yet available.

References

[1] N. C. Olarescu, K. Gunawardane, T. K. Hanson, N. Møller, and J. O. L. Jørgensen, “Normal Physiology of Growth Hormone in Normal Adults,” Endotext, [Online]. Available: https://www.ncbi.nlm.nih.gov/books/NBK279056/.

[2] A. Vijayakumar, R. Novosyadlyy, Y. J. Wu, S. Yakar, and D. LeRoith, “Biological Effects of Growth Hormone on Carbohydrate and Lipid Metabolism,” Growth Horm. IGF Res., vol. 20, no. 1, p. 1, Feb. 2009, doi: 10.1016/J.GHIR.2009.09.002.

[3] A. Vijayakumar, S. Yakar, and D. LeRoith, “The Intricate Role of Growth Hormone in Metabolism,” Front. Endocrinol. (Lausanne)., vol. 2, no. SEP, p. 32, 2011, doi: 10.3389/FENDO.2011.00032.

[4] M. Caputo et al., “Regulation of GH and GH Signaling by Nutrients,” Cells, vol. 10, no. 6, p. 1376, Jun. 2021, doi: 10.3390/CELLS10061376.

[5] E. Gurevich, Y. Segev, and D. Landau, “Growth Hormone and IGF1 Actions in Kidney Development and Function,” Cells, vol. 10, no. 12, p. 3371, Dec. 2021, doi: 10.3390/CELLS10123371.

[6] D. Haffner, A. Grund, and M. Leifheit-Nestler, “Renal effects of growth hormone in health and in kidney disease,” Pediatr. Nephrol., vol. 36, no. 8, p. 2511, Aug. 2021, doi: 10.1007/S00467-021-05097-6.

[7] V. Cingel-Ristić, A. Flyvbjerg, and S. L. S. Drop, “The physiological and pathophysiological roles of the GH/IGF-axis in the kidney: Lessons from experimental rodent models,” Growth Horm. IGF Res., vol. 14, no. 6, pp. 418–430, Dec. 2004, doi: 10.1016/J.GHIR.2004.06.003.

[8] M. Ávila, M. G. Mora Sánchez, A. S. Bernal Amador, and R. Paniagua, “The Metabolism of Creatinine and Its Usefulness to Evaluate Kidney Function and Body Composition in Clinical Practice,” Biomolecules, vol. 15, no. 1, p. 41, Jan. 2025, doi: 10.3390/BIOM15010041.

[9] C. Thongprayoon, W. Cheungpasitporn, and K. Kashani, “Serum creatinine level, a surrogate of muscle mass, predicts mortality in critically ill patients,” J. Thorac. Dis., vol. 8, no. 5, p. E305, May 2016, doi: 10.21037/JTD.2016.03.62.

[10] A. Hadzović, E. Nakas-Ićindić, E. Kucukalić-Selimović, and A. U. Salaka, “GROWTH HORMONE (GH): USAGE AND ABUSE,” Bosn. J. Basic Med. Sci., vol. 4, no. 4, p. 66, 2004, doi: 10.17305/BJBMS.2004.3365.

[11] M. Lisbona-Buzali et al., “Unconventional Uses of Human Growth Hormone,” Arch. Med. Res., vol. 57, no. 5, p. 103412, Jul. 2026, doi: 10.1016/J.ARCMED.2026.103412.

[12] M. Saugy, N. Robinson, C. Saudan, N. Baume, L. Avois, and P. Mangin, “Human growth hormone doping in sport,” Br. J. Sports Med., vol. 40, no. Suppl 1, p. i35, Jul. 2006, doi: 10.1136/BJSM.2006.027573.

[13] R. G. Holt, “Detecting growth hormone misuse in athletes,” Indian J. Endocrinol. Metab., vol. 17, no. Suppl1, p. S18, 2013, doi: 10.4103/2230-8210.119494.

[14] M. Ávila, M. G. Mora Sánchez, A. S. Bernal Amador, and R. Paniagua, “The Metabolism of Creatinine and Its Usefulness to Evaluate Kidney Function and Body Composition in Clinical Practice,” Biomol. 2025, Vol. 15, Page 41, vol. 15, no. 1, p. 41, Jan. 2025, doi: 10.3390/BIOM15010041.

[15] A. Melillo, “Rabbit Clinical Pathology,” J. Exot. Pet Med., vol. 16, no. 3, p. 135, Jul. 2007, doi: 10.1053/J.JEPM.2007.06.002.

[16] S. Al-Samerria and S. Radovick, “The Role of Insulin-like Growth Factor-1 (IGF-1) in the Control of Neuroendocrine Regulation of Growth,” Cells, vol. 10, no. 10, p. 2664, Oct. 2021, doi: 10.3390/CELLS10102664.

[17] C. P. Velloso, “Regulation of muscle mass by growth hormone and IGF-I,” Br. J. Pharmacol., vol. 154, no. 3, p. 557, Jun. 2008, doi: 10.1038/BJP.2008.153.

[18] A. B. W. Tavares et al., “Effects of Growth Hormone Administration on Muscle Strength in Men over 50 Years Old,” Int. J. Endocrinol., vol. 2013, p. 942030, 2013, doi: 10.1155/2013/942030.